UNSPSC 51452306: Pyrantel embonate

This classification denotes an antihelminthic agent with the molecular formula C23H16O6.C11H14N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 81BK194Z5M, chemically known as 4,4-methylenebis(3-hydroxy-2-naphthoic) acid, compound with (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine (1:1) but more generally known as pyrantel embonate, which bears US NIH Compound Identifier 5281033.

European Medicines Agency schedules Pyrantel embonate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04132MIG. Most nations, for tariff and trade purposes, schedule pyrantel embonate under HS 29349990 and SITC 51579. SMILES: CN1CCCN=C1/C=C/C2CCCS2.C1CCC2C(C1)CC(C(C2CC3C4CCCCC4CC(C3O)C(=O)O)O)C(=O)O.

UNSPSC 51452306 Pyrantel embonate is a Commodity code for a specific antiparasitic pharmaceutical, yet recent state and local procurement activity under this code shows little direct alignment with the named product itself. The opportunities posted indicate that state and local health agencies and purchasing cooperatives are soliciting broader pharmaceutical portfolios—including naloxone, generic multi-source medications, over-the-counter products, and direct-to-manufacturer prescription programs—rather than pyrantel embonate specifically. The mismatch between the code's nominal scope and the work actually being bought suggests this code sees limited recent activity in state and local procurement, or that tagging practices do not consistently reflect the true product mix being sourced.

The recent opportunities that do carry this code span health departments, cooperative purchasing alliances, and municipal fire departments across Florida, Texas, and Minnesota. Seminole County, Florida posted an IFB (IFB60459723LAS) in June 2026 to procure naloxone and drug deactivation systems for community health initiatives, with quarterly deliveries and a response deadline of July 26, 2023; the City of Tampa's Purchasing Department issued an IFB (26P00145) in March 2026 for medical and first aid supplies for the Fire Department Rescue Division, with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises; the Minnesota Department of Administration issued an RFP through MMCAP (S1070000015802) for generic pharmaceuticals and OTC products distributed across state and local facilities, with proposals due March 26, 2026 and a 75 percent weight on price competitiveness; and the Texas Health and Human Services Commission posted an RFI (HHS0017013) in April 2026 to gather vendor capabilities for a direct-to-manufacturer pharmacy program. The geographic concentration in these three states, the diversity of issuing bodies, and the emphasis on lowest-price-responsive-responsible awards across opportunities suggest procurement activity is fragmented by jurisdiction rather than consolidated under a single program or vendor base.